Splanchnic vein thrombosis in myeloproliferative neoplasms

Etiology, Management, and Outcome of the Budd-Chiari Syndrome

(2013) Sarwa Darwish Murad   ANNALS OF INTERNAL MEDICINE

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis

(2012) T. Barbui et al.   BLOOD

JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway

(2012) M. De Grandis et al.   BLOOD

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

(2012) J. H. Smalberg et al.   BLOOD

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

(2012) P. J. Campbell et al.   BLOOD

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation

(2012) V. Rosti et al.   BLOOD

Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications

(2012) Sandra Malak et al.   BLOOD CELLS MOLECULES AND DISEASES

Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt

(2012) Alexandra Zahn et al.   BMC GASTROENTEROLOGY

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection ofJAK2V617F and other relevant mutations

(2012) Anthony J. Bench et al.   BRITISH JOURNAL OF HAEMATOLOGY

Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia

(2012) Caterina Musolino et al.   CLINICAL BIOCHEMISTRY

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

(2012) Erica Villa et al.   GASTROENTEROLOGY

Spleens of myelofibrosis patients contain malignant hematopoietic stem cells

(2012) Xiaoli Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

The JAK2 V617F mutation in patients with cerebral venous thrombosis

(2012) S. M. PASSAMONTI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Age-related differences in disease characteristics and clinical outcomes in polycythemia vera

(2012) Brady L. Stein et al.   LEUKEMIA & LYMPHOMA

Non conventional mutations associated with myeloproliferative disorders are absent in splanchnic venous thrombosis cases

(2012) Anshul Jadli et al.   LIVER INTERNATIONAL

Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis

(2012) Marco Senzolo et al.   LIVER INTERNATIONAL

Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in budd-chiari syndrome and their impact on thrombotic complications post Liver Transplantation

(2012) Rachel H. Westbrook et al.   LIVER TRANSPLANTATION

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition

(2012) Sonam Prakash et al.   MODERN PATHOLOGY

Clinical approach to splanchnic vein thrombosis: Risk factors and treatment

(2012) Nicoletta Riva et al.   THROMBOSIS RESEARCH

Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera

(2011) Marina Panova-Noeva et al.   AMERICAN JOURNAL OF HEMATOLOGY

JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis

(2011) Valerio De Stefano et al.   AMERICAN JOURNAL OF HEMATOLOGY

Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg

(2011) Mandy N. Lauw et al.   ANNALS OF HEMATOLOGY

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients

(2011) M. Panova-Noeva et al.   BLOOD

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis

(2011) J. H. Smalberg et al.   BLOOD

The JAK2 46/1 haplotype in splanchnic vein thrombosis

(2011) E. Kouroupi et al.   BLOOD

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms

(2011) L. Teofili et al.   BLOOD

Polycythemia vera: gender-related phenotypic differences

(2011) Raffaele Landolfi et al.   Internal and Emergency Medicine

Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: A prospective study

(2011) Xingshun Qi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms

(2011) J. HOEKSTRA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study

(2011) W. AGENO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera

(2011) H Reikvam et al.   LEUKEMIA

JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms

(2011) Laura Villani et al.   LEUKEMIA RESEARCH

Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis

(2011) Donatella Colaizzo et al.   THROMBOSIS RESEARCH

The epidemiology and clinical features of portal vein thrombosis: a multicentre study

(2010) R. Rajani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis

(2010) D. W. ORR et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JAK2Mutations Across a Spectrum of Venous Thrombosis Cases: Table 1

(2010) Shrimati Shetty et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Thrombohemorrhagic complications of myeloproliferative disorders

(2010) Emmanouil Papadakis et al.   BLOOD REVIEWS

Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders

(2010) B. L. Stein et al.   HAEMATOLOGICA

Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked

(2010) M. A. Elliott et al.   HAEMATOLOGICA

Portal Vein Thrombosis After Laparoscopic and Open Splenectomy

(2010) Rosario Vecchio et al.   Journal of Laparoendoscopic & Advanced Surgical Techniques

Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience

(2010) Rupesh Rajani et al.   LIVER INTERNATIONAL

High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis

(2010) Vittorio Rosti et al.   PLoS One

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms

(2010) Giuseppe Cella et al.   THROMBOSIS AND HAEMOSTASIS

Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms

(2010) Jérôme Duchemin et al.   THROMBOSIS RESEARCH

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

(2009) G. Piaggio et al.   BLOOD

Thrombosis in primary myelofibrosis: incidence and risk factors

(2009) T. Barbui et al.   BLOOD

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

(2009) F. Dentali et al.   BLOOD

The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome

(2009) S. Sozer et al.   BLOOD

Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome

(2009) Donatella Colaizzo et al.   BLOOD COAGULATION & FIBRINOLYSIS

Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients

(2009) Alberto Alvarez-Larrán et al.   BRITISH JOURNAL OF HAEMATOLOGY

Survival and Recurrence in Patients With Splanchnic Vein Thromboses

(2009) Mallikarjun R. Thatipelli et al.   Clinical Gastroenterology and Hepatology

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

(2009) Sandra Guerra Xavier et al.   DIGESTIVE DISEASES AND SCIENCES

Pregnancy: a risk factor for Budd-Chiari syndrome?

(2009) P-E Rautou et al.   GUT

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia

(2009) M. C. Trappenburg et al.   HAEMATOLOGICA

Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia

(2009) V. De Stefano et al.   HAEMATOLOGICA

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study

(2009) Aurelie Plessier et al.   HEPATOLOGY

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

(2009) Damla Olcaydu et al.   NATURE GENETICS

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

(2009) Amy V Jones et al.   NATURE GENETICS

Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden

(2008) Eduardo Arellano-Rodrigo et al.   AMERICAN JOURNAL OF HEMATOLOGY

Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera

(2008) M. Marchetti et al.   BLOOD

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD

Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence

(2008) J.-J. Lataillade et al.   BLOOD

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

(2008) F. Passamonti et al.   HAEMATOLOGICA

Vascular disorders of the liver

(2008) Laurie D. DeLeve et al.   HEPATOLOGY

Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia

(2008) Alessandra Carobbio et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatic Vascular Involvement Related to Pregnancy, Oral Contraceptives, and Estrogen Replacement Therapy

(2008) Jean-Marc Perarnau et al.   SEMINARS IN LIVER DISEASE